JENTADUETO

This brand name is authorized in United States. It is also authorized in Austria, Canada, Croatia, Cyprus, Estonia, Finland, Ireland, Italy, Lithuania, Netherlands, Poland, Romania, Spain, Tunisia, UK.

Active ingredients

The drug JENTADUETO contains a combination of these active pharmaceutical ingredients (APIs):

1	Linagliptin UNII 3X29ZEJ4R2 - LINAGLIPTIN
	Linagliptin is an inhibitor of the enzyme DPP-4 (dipeptidyl peptidase 4, EC 3.4.14.5) an enzyme which is involved in the inactivation of the incretin hormones GLP-1 and GIP (glucagon-like peptide1, glucose-dependent insulinotropic polypeptide). These hormones are rapidly degraded by the enzyme DPP-4. Both incretin hormones are involved in the physiological regulation of glucose homeostasis.
	Read more about Linagliptin
2	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
JENTADUETO Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD11	Metformin and linagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD11

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02403250, 02403269, 02403277
EE	Ravimiamet	1590410, 1590421, 1590432, 1590443, 1590454, 1590465, 1590476, 1590487, 1590498, 1590500, 1590511, 1590533, 1590544, 1590555, 1590566, 1590577, 1590588, 1590599, 1590601, 1590612, 1590623, 1590634, 1590645, 1590656, 1597989, 1597990
ES	Centro de información online de medicamentos de la AEMPS	12780006, 12780006IP, 12780020, 12780020IP
FI	Lääkealan turvallisuus- ja kehittämiskeskus	065662, 563184
GB	Medicines & Healthcare Products Regulatory Agency	212083, 212086, 377480, 381428, 381433
IE	Health Products Regulatory Authority	53875, 53876
IT	Agenzia del Farmaco	042203012, 042203024, 042203036, 042203048, 042203051, 042203063, 042203075, 042203087, 042203099, 042203101, 042203113, 042203125, 042203137, 042203149, 042203152, 042203164, 042203176, 042203188, 042203190, 042203202, 042203214, 042203226, 042203238, 042203240, 042203253, 042203265, 042203277, 042203289, 042203291, 042203303, 042203315, 042203327, 042203339, 042203341, 042203354, 042203366
LT	Valstybinė vaistų kontrolės tarnyba	1067161, 1067162, 1067163, 1067164, 1067165, 1067166, 1067167, 1067168, 1067169, 1067170, 1067171, 1067172, 1067173, 1067174, 1067175, 1067176, 1067177, 1067178, 1067179, 1067180, 1067181, 1067182, 1067183, 1067184, 1067185, 1067186, 1067187, 1067188, 1068379, 1068380, 1068381, 1068382, 1068383, 1068384, 1090527, 1090528
NL	Z-Index G-Standaard, PRK	102768, 102776
PL	Rejestru Produktów Leczniczych	100282120, 100282136
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W59021001, W59021002, W59021003, W59021004, W59021005, W59021006, W59021007, W59021008, W59021009, W59021010, W59021011, W59021012, W59021013, W59021014, W59023001, W59023002, W59023003, W59023004, W59023005, W59023006, W59023007, W59023008, W59023009, W59023010, W59023011, W59023012, W59023013, W59023014
TN	Direction de la Pharmacie et du Médicament	11533062, 11533063
US	FDA, National Drug Code	0597-0146, 0597-0147, 0597-0148, 0597-0270, 0597-0275